pyrroles has been researched along with Guillain-Barre Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, LL; Dou, YC; Duan, RS; Li, XL; Liu, Y; Shi, CW; Zhang, XQ; Zhu, J | 1 |
| Holen, KD; Loconte, NK; Mulherin, B | 1 |
1 review(s) available for pyrroles and Guillain-Barre Syndrome
| Article | Year |
|---|---|
Guillain-Barré syndrome after treatment with sunitinib malate?
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Gastrointestinal Stromal Tumors; Guillain-Barre Syndrome; Humans; Indoles; Kidney Neoplasms; Pyrroles; Sunitinib | 2008 |
1 other study(ies) available for pyrroles and Guillain-Barre Syndrome
| Article | Year |
|---|---|
Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells.
Topics: Animals; Atorvastatin; Cattle; Cytokines; Female; Guillain-Barre Syndrome; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunization; Interferon-gamma; Interleukin-17; Myelin Sheath; Neuritis, Autoimmune, Experimental; Pyrroles; Rats; Rats, Inbred Lew; Sciatic Nerve; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells | 2011 |